- 1、本文档共6页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
急性白血病外周血T细胞CD28和CD137的表达_药学论文
急性白血病外周血T细胞CD28和CD137的表达_药学论文
作者:马肖容 张王刚 杨惠云 田玮
【关键词】 ,CD28
Expression of CD28 and CD137 in peripheral blood T cells in acute leukemia
【Abstract】 AIM: To study the expression characteristics of costimulatory molecules CD28 and CD137 (41BB) in peripheral blood T cells in human leukemia before and after the chemotherapy and to explore their significance in antileukemia immunity. METHODS: The expression of costimulatory molecules CD28 and CD137 in T cells was measured in 38 patients with acute leukemia (AL) before and after chemotherapy by immunofluorescence and FACS. The peripheral blood T lymphocyte subsets were also analyzed. RESULTS: ① The level of CD28, CD3, CD4 and CD4/CD8 in AL patients before chemotherapy was lower but CD137 was higher than those in control markedly (0.05). ② The level of CD28, CD3, CD4 and CD4/CD8 increased in complete remission (CR) and partial remission (PR) patients after chemotherapy but CD137 decreased distinctly compared with that before chemotherapy (0.05). The level in CR patients was close to that in the control. No significant change was found in nonremission (NR) patients (Pgt;0.05). CONCLUSION: CD28 and CD137 are important costimulatory molecules during the pathogenesis of AL and antileukemia immunity. Their abnormal level may partly be responsible for AL and be closely related with the clinical curative effects. It may be an important means to treat human leukemia immunogenetically by regulating the expression of CD28 and CD137 in T cells and by correcting the immunodeficiency of AL patients.
【Keywords】 CD28; CD137; T lymphocyte; acute leukemia
【摘要】 目的:研究共刺激分子CD28和CD137(41BB)在人急性白血病(AL)治疗前后外周血T细胞上的表达特点,探讨其与临床疗效的关系. 方法:应用免疫荧光标记及流式细胞术(FACS)检测了38例AL患者治疗前后外周血T细胞表面共刺激分子CD28和CD137的表达,并分析了T淋巴细胞亚群变化情况. 结果:①治疗前AL患者CD28, CD3, CD4, CD4/CD8较对照组显著降低,而CD137显著增高(0.05);②治疗后完全缓解(CR)和部分缓解(PR)患者CD28, CD3, CD4, CD4/CD8均较其治疗前显著增高,而CD137显著降低(0.05),CR患者接近对照者,而未缓解(NR)患者以上指标无显著变化(Pgt;0.05). 结论:CD28和CD137是参与急性白血病发病和抗白血
文档评论(0)